- Report
- October 2025
- 150 Pages
Germany
From €3394EUR$3,850USD£2,981GBP
- Report
- September 2025
- 150 Pages
China
From €3394EUR$3,850USD£2,981GBP
- Report
- November 2024
- 150 Pages
Global
From €3394EUR$3,850USD£2,981GBP
€4276EUR$4,850USD£3,756GBP
- Report
- July 2024
Global
From €3394EUR$3,850USD£2,981GBP
€4276EUR$4,850USD£3,756GBP
- Report
- February 2022
- 80 Pages
Global
From €1763EUR$2,000USD£1,549GBP
- Report
- February 2022
- 37 Pages
Global
From €1763EUR$2,000USD£1,549GBP
- Drug Pipelines
- October 2020
- 773 Pages
Global
From €1763EUR$2,000USD£1,549GBP
- Drug Pipelines
- August 2020
- 345 Pages
Global
From €1763EUR$2,000USD£1,549GBP
- Drug Pipelines
- July 2020
- 197 Pages
Global
From €1763EUR$2,000USD£1,549GBP
- Report
- September 2025
- 150 Pages
Canada
From €3394EUR$3,850USD£2,981GBP
- Report
- December 2024
- 150 Pages
Global
From €3394EUR$3,850USD£2,981GBP
€4276EUR$4,850USD£3,756GBP
- Report
- July 2024
Global
From €3394EUR$3,850USD£2,981GBP
€4276EUR$4,850USD£3,756GBP
- Report
- March 2024
- 150 Pages
Global
From €3394EUR$3,850USD£2,981GBP
€4276EUR$4,850USD£3,756GBP
- Report
- February 2024
- 150 Pages
Global
From €3394EUR$3,850USD£2,981GBP
€4276EUR$4,850USD£3,756GBP
- Report
- June 2023
- 111 Pages
Global
From €3967EUR$4,500USD£3,485GBP
- Report
- September 2024
- 200 Pages
Global
From €4363EUR$4,949USD£3,832GBP
- Report
- April 2023
- 147 Pages
Global
From €4363EUR$4,949USD£3,832GBP
- Report
- September 2024
- 250 Pages
Global
From €4363EUR$4,949USD£3,832GBP
- Report
- August 2024
- 160 Pages
United States
From €3173EUR$3,599USD£2,787GBP
- Report
- July 2024
- 200 Pages
Global
From €4363EUR$4,949USD£3,832GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more